51
SINUPRET IN THE COMPLEX THERAPY OF PURPOSE
RHINOSINUSITIS IN PREGNANT WOMEN
Akhmedova Shakhnoza, 501 group student of The faculty of medical work
and medical pedagogy.
Scientific adviser: ass. Ismatova
К
. A.
TashPMI, Department of Otorhinolaryngology, Pediatric
Otorhinolaryngology and Pediatric Dentistry
Relevance:
Patients with diseases of the paranasal sinuses make up, according to various sources,
from 15% to 62% of the total number of those who applied to ENT hospitals, ENT offices of polyclinic
medical institutions. .Approximately 30% of women experience rhinitis symptoms during pregnancy.
Material and methods of research
: We observed 60 pregnant women from 12 to 37 weeks with
purulent rhinosinusitis. For the diagnosis of purulent rhinosinusitis established on the basis of
characteristic complaints, data of rhinoscopy, pharyngoscopy, endoscopic examination of the nose and
nasopharynx and ultrasound of the paranasal sinuses. The criteria for the diagnosis of purulent
rhinosinusitis were; the duration of the disease is more than 7-10 days; cough, nasal congestion, headache
All women underwent complex treatment of purulent sinusitis. In the main group, along with complex
treatment, Sinupret is used in the form of tablets
Result:
The dose of the drug is 1 tablet 3 times a day. within 10-12 days. Dragee is taken without
biting inside with a small amount of liquid. The thick mucous membranes of purulent pregnant women
who received Sinupret liquefied, which led to a decrease in nasal congestion after the first two or three
days, the general condition improved and the pregnant women began to feel better in relation to the
control group. No side effects were observed while taking Sinupret. A positive result was noted from the
third day of treatment. Thus, free breathing was registered in 73.6% of the main group. Purulent discharge
was absent in 34.6% of the control group and 86.7% in the main.
Conclusion:
Patients with purulent rhinosinusitis who took Sinupret showed a faster recovery
and recovery of working capacity, in contrast to those who received only basic therapy. Sinupret was
noted for a faster regression and a decrease in the amount of discharge in the nasal cavity, paranasal
sinuses and on the posterior pharyngeal wall.
References:
1.
Хайдаров
,
М
.,
И
.
Маматкулов
,
Н
.
Зокирова
,
и М
.
Толипов
. «
Осложнения инфузионной
терапии в реанимации и интенсивной терапии
», in Library,
т
. 22,
вып
. 1,
март
2021
г
.,
сс
. 120-
5, https://inlibrary.uz/index.php/archive/article/view/18898.
2.
Мищенко
,
Т
.
С
., and
И
.
В
.
Здесенко
. "
Терапевтические возможности коррекции венозных
нарушений при дисциркуляторной энцефалопатии
."
Международный неврологический
журнал
2 (56) (2013): 141-146.
3.
Дон
,
Андрей
. "
Гистоморфометрия аденогипофиза и щитовидной железы под влиянием
ладыгинозида в эксперименте
."
Медицина и инновации
1.4 (2021): 55-63.
